Product SynopsisIn 2012, the scale of China’s TPMS market was CNY 1.4 billion, and this number is expected to exceed CNY 1.5 billion in 2013. Although China’s TPMS market has maintained rapid growth in recent years, the market scale is still relatively small compared with other automotive electronics products (such as EMS, ABS, automotive audio, airbags and auto instruments), and this industry is still in the initial stage of development. As of 2012, there were nearly 200 TPMS manufacturers in China, but the technology level is uneven; only few manufacturers, such as Baolong, Kysonix, Top Sun, State and Taihao can achieve mass production. In addition to TPMS, most of the enterprises also produce reversing radars, GPS navigations, alarms, central locking systems and a series of... Read More
Table Of Content
Make an enquiry before buying this Report
Please fill the enquiry form below.
By - Transparency
Increasing incidences of sudden cardiac arrests, growth in the use of robotic guided catheters in diagnostic procedures, and increase in the arrhythmia population are some of the major factors driving the growth of electrophysiology devices industry. Need to reduce diagnostic procedure time, improve success rate, and reduce human exposure to radiations is driving technological innovations in this industry. The global electrophysiology (EP) devices market is expected to witness significant growth rate and reach USD 4.4 billion by 2015 at a CAGR of 9.7% during the forecast...
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the limestone market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the limestone market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
By - Transparency
Organ transplant immunosuppressants are a class of drugsadministered to lower the chances of organ rejection after a transplant and are also called as anti-rejection drugs. When a person gets an organ transplant such as kidney, liver or heart, the body identifies transplant as a foreign tissue and attacks it causing severe rejection. These immunosuppressant drugs weaken the immune system thereby decreasing the body’s reaction totransplant. Almost every person undergoing a solid organ transplant requires to take immunosuppressant drugs. Therefore the global market for these drugs is...